Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.11M | 14.94M | 8.69M | 11.04M | 7.75M | 5.24M |
Gross Profit | 5.26M | 3.47M | -3.34M | 2.00M | 838.61K | 205.70K |
EBITDA | -972.60K | -1.29M | -5.89M | 1.28M | 832.88K | -2.38M |
Net Income | -861.11K | -1.73M | -6.35M | 428.66K | -227.94K | -3.34M |
Balance Sheet | ||||||
Total Assets | 28.58M | 34.64M | 28.09M | 34.70M | 35.00M | 13.30M |
Cash, Cash Equivalents and Short-Term Investments | 11.97M | 18.17M | 11.97M | 19.06M | 21.36M | 665.10K |
Total Debt | 28.44K | 1.08M | 28.44K | 312.00K | 215.15K | 629.83K |
Total Liabilities | 3.06M | 6.04M | 2.57M | 2.83M | 2.63M | 6.11M |
Stockholders Equity | 25.52M | 28.60M | 25.52M | 31.87M | 32.37M | 7.19M |
Cash Flow | ||||||
Free Cash Flow | -814.41K | 1.79M | -6.28M | -1.98M | -3.08M | -1.55M |
Operating Cash Flow | 425.99K | 2.22M | -4.75M | -249.28K | -2.43M | -1.31M |
Investing Cash Flow | -902.05K | -42.07K | -1.34M | -1.79M | -653.13K | -243.09K |
Financing Cash Flow | 7.40M | 4.14M | -1.07M | -267.73K | 23.78M | 2.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $10.11B | 9.76 | -0.15% | 2.94% | 2.14% | -32.15% | |
50 Neutral | $145.28M | ― | -19.11% | ― | ― | ― | |
47 Neutral | $354.46M | ― | -814.96% | ― | ― | ― | |
45 Neutral | $234.63M | ― | -4.38% | ― | 105.14% | 84.95% | |
$322.43M | ― | -303.62% | ― | ― | ― | ||
40 Underperform | $169.38M | ― | -4.74% | ― | ― | -173.39% | |
35 Underperform | $943.15M | ― | -40.55% | ― | ― | -15.85% |
On June 27, 2025, United States Antimony Corporation received approval from NYSE Texas, Inc. to list its common stock on the NYSE Texas Exchange, with trading set to begin on July 1, 2025. The company will continue to maintain its primary listing on the NYSE American Stock Exchange under the ticker symbol ‘UAMY’, potentially enhancing its market presence and accessibility for investors.
The most recent analyst rating on (UAMY) stock is a Buy with a $1.00 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On March 17, 2025, United States Antimony Corporation faced a significant operational challenge when a shipment of 50 tons of stibnite ore was delayed by Chinese Customs for 82 days without explanation. Despite efforts to resolve the issue, the shipment was ultimately returned to Australia, potentially due to China’s ban on antimony exports, impacting the company’s supply chain and operations.
The most recent analyst rating on (UAMY) stock is a Buy with a $1.00 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On March 11, 2024, United States Antimony Corporation announced its decision to discontinue all Latin American operations and dispose of its subsidiary, US Antimony de Mexico, due to historical negative cash flow. As of April 21, 2025, the company has restarted its Madero Smelter Plant in Mexico, processing international antimony ore shipments with a production target of 200 tons per month by the end of 2025.